• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 RADIANCE-HTN SOLO 试验中,与血管内超声肾去神经支配相关的血浆肾素和醛固酮浓度。

Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial.

机构信息

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, New York, USA.

出版信息

J Hypertens. 2022 Feb 1;40(2):221-228. doi: 10.1097/HJH.0000000000002994.

DOI:10.1097/HJH.0000000000002994
PMID:34433763
Abstract

OBJECTIVE

The RADIANCE-HTN SOLO trial demonstrated a greater reduction in daytime ambulatory SBP at 2 months by endovascular ultrasound renal denervation than sham procedure. We hypothesized that plasma renin and aldosterone concentrations would be associated with the SBP response to renal denervation.

METHODS

Hypertensive patients were randomized to renal denervation (n = 74) or sham (n = 72) after a 4-week washout of antihypertensive medications. In a 53-patient subset, 2-month and 6-month plasma renin and aldosterone concentration were measured. Dietary sodium was not controlled.

RESULTS

Mean age of the 29 treatment and 24 sham patients was 54 years; 62% were men; 17% black. Daytime ambulatory SBP fell in the denervation but not the sham group at 2 months (-7.8 ± 10.7 vs. -0.1 ± 10.1 mmHg; P = 0.048). Baseline plasma renin and aldosterone concentrations were in the low-normal range, did not change significantly at 2 months in either group and did not predict response to renal denervation. At 6 months, after the addition of antihypertensive medications, there was a significant rise in renin in the sham but not the denervation group.

CONCLUSION

Although renal denervation but not sham resulted in a decrease in daytime ambulatory SBP at 2 months, renin and aldosterone concentrations did neither predict the BP response to renal denervation; nor did they fall after denervation. A rise in renin at 6 months in the sham group likely represents confounding from antihypertensive medications. Whether the BP-lowering effect of renal denervation depends on reducing local intrarenal renin release requires further study.

摘要

目的

RADIANCE-HTN SOLO 试验表明,与假手术相比,血管内超声肾动脉去神经术在 2 个月时可更大程度地降低日间动态收缩压。我们假设血浆肾素和醛固酮浓度与肾去神经术的血压反应有关。

方法

在停止使用降压药物 4 周后,高血压患者被随机分为肾去神经组(n = 74)或假手术组(n = 72)。在一个 53 例患者的亚组中,测量了 2 个月和 6 个月时的血浆肾素和醛固酮浓度。未控制饮食中的钠含量。

结果

29 例治疗组和 24 例假手术组患者的平均年龄为 54 岁;62%为男性;17%为黑人。在 2 个月时,去神经组的日间动态收缩压下降,但假手术组没有(-7.8 ± 10.7 与-0.1 ± 10.1 毫米汞柱;P = 0.048)。基线时血浆肾素和醛固酮浓度处于低正常范围,两组在 2 个月时均无明显变化,也不能预测肾去神经术的反应。6 个月时,在添加降压药物后,假手术组肾素显著升高,但去神经组没有。

结论

尽管肾去神经术而非假手术在 2 个月时可降低日间动态收缩压,但肾素和醛固酮浓度既不能预测肾去神经术的血压反应;也不会在去神经术后下降。假手术组在 6 个月时肾素升高可能是降压药物引起的混杂因素。肾去神经术的降压作用是否取决于减少局部肾内肾素释放,需要进一步研究。

相似文献

1
Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial.在 RADIANCE-HTN SOLO 试验中,与血管内超声肾去神经支配相关的血浆肾素和醛固酮浓度。
J Hypertens. 2022 Feb 1;40(2):221-228. doi: 10.1097/HJH.0000000000002994.
2
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.血管内超声肾脏去神经治疗高血压:RADIANCE II 随机临床试验。
JAMA. 2023 Feb 28;329(8):651-661. doi: 10.1001/jama.2023.0713.
3
Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program.药物升级治疗 6 个月后血管内超声肾脏去神经术或假手术的患者水平汇总分析:RADIANCE 临床试验项目。
Circulation. 2024 Mar 5;149(10):747-759. doi: 10.1161/CIRCULATIONAHA.123.066941. Epub 2023 Oct 26.
4
Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial.药物升级后抵抗性高血压行肾去神经术与假手术对照的效果:RADIANCE-HTN TRIO 随机临床试验 6 个月时的预设分析。
JAMA Cardiol. 2022 Dec 1;7(12):1244-1252. doi: 10.1001/jamacardio.2022.3904.
5
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials.超声去肾神经术在 RADIANCE II、RADIANCE-HTN SOLO 和 RADIANCE-HTN TRIO 试验的患者水平汇总分析。
JAMA Cardiol. 2023 May 1;8(5):464-473. doi: 10.1001/jamacardio.2023.0338.
6
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.超声去肾交感神经治疗高血压的 RADIANCE-HTN SOLO 试验盲态期 12 个月结果
JACC Cardiovasc Interv. 2020 Dec 28;13(24):2922-2933. doi: 10.1016/j.jcin.2020.09.054.
7
Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.RADIANCE-HTN SOLO试验中,随机接受血管内超声肾去神经术或假手术治疗后,进行治疗盲法药物滴定以控制高血压的六个月结果。
Circulation. 2019 May 28;139(22):2542-2553. doi: 10.1161/CIRCULATIONAHA.119.040451. Epub 2019 Mar 17.
8
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.血管内超声肾去神经术治疗高血压(RADIANCE-HTN SOLO):一项多中心、国际、单盲、随机、假对照试验。
Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23.
9
Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.动态血压监测预测肾去神经术反应:RADIANCE-HTN SOLO 研究的事后分析。
Hypertension. 2021 Feb;77(2):529-536. doi: 10.1161/HYPERTENSIONAHA.120.16292. Epub 2020 Dec 28.
10
Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation.肾动脉交感神经去神经支配后血浆肾素活性的变化。
J Am Coll Cardiol. 2021 Jun 15;77(23):2909-2919. doi: 10.1016/j.jacc.2021.04.044. Epub 2021 May 3.

引用本文的文献

1
Renal denervation for hypertension.用于治疗高血压的肾去神经支配术。
Nat Rev Cardiol. 2025 Jan 2. doi: 10.1038/s41569-024-01104-z.
2
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations.SCAI关于高血压肾去神经支配的立场声明:患者选择、术者能力、培训与技术以及组织建议
J Soc Cardiovasc Angiogr Interv. 2023 Aug 21;2(6Part A):101121. doi: 10.1016/j.jscai.2023.101121. eCollection 2023 Nov-Dec.
3
Histological examination of renal nerve distribution, density, and function in humans.
人类肾神经分布、密度和功能的组织学检查。
EuroIntervention. 2023 Sep 18;19(7):612-620. doi: 10.4244/EIJ-D-23-00264.
4
Long-term follow-up of patients undergoing renal sympathetic denervation.接受肾交感神经切除术患者的长期随访。
Clin Res Cardiol. 2022 Nov;111(11):1256-1268. doi: 10.1007/s00392-022-02056-5. Epub 2022 Jul 18.